GSA Capital Partners’s Vigil Neuroscience VIGL Stock Holding History

GSA Capital Partners’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-44,179	Closed	-$351K	–	2131
2025 Q2	$351K	Buy	44,179 +3,051	+7%	+$13.7K	0.02%	1163
2025 Q1	$73K	Buy	+41,128	New	+$92.3K	0.01%	1529

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

GSA Capital Partners's VIGL Position: Q3 2025 in Review

GSA Capital Partners sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 44,179 shares — an estimated $351K sold.

GSA Capital Partners first reported a position in VIGL in Q1 2025 and held it in 2 quarters. The position peaked at $351K in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

GSA Capital Partners reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
GSA Capital Partners sold 44,179 Vigil Neuroscience shares in Q3 2025, an estimated $351K.
GSA Capital Partners first reported a position in Vigil Neuroscience in Q1 2025 and held it in 2 quarters.
GSA Capital Partners's Vigil Neuroscience position peaked at $351K in Q2 2025.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on GSA Capital Partners's 13F filing for Q3 2025, filed 7 Nov 2025.